Tag: CIRSE 2016
SOLSTICE preliminary data show cryoablation has “acceptable safety profile” in treatment...
The SOLSTICE clinical study constitutes the largest multicentre, prospective study focused on the clinical use and effectiveness of cryotherapies for patients with primary cancer...
Majority of patients treated with embolization for symptomatic fibroids can avoid...
Ten-year outcomes from the randomised controlled EMMY trial were presented at CIRSE 2016 (10–14 September, Barcelona, Spain) by Jim Reekers, Academic Medical Center, Amsterdam,...
Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent
The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) in the treatment of femoropopliteal artery...
CIRSE 2016: Following the beat of modern interventions
See you in Barcelona, September 10-14, for CIRSE 2016 – the world’s largest interventional radiology congress. ...
